Avanos Medical, Inc. (NYSE: AVNS) reported Q1 EPS of $0.22, $0.04 worse than the analyst estimate of $0.26. Revenue for the quarter came in at $166.1 million versus the consensus estimate of $162.93 million.

GUIDANCE:

Avanos Medical, Inc. sees FY2024 EPS of $1.30-$1.45, versus the consensus of $1.38. Avanos Medical, Inc. sees FY2024 revenue of $685-705 million, versus the consensus of $691.1 million.

For earnings history and earnings-related data on Avanos Medical, Inc. (AVNS) click here.